Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Group 1: Company Overview - National Health Investors (NHI) currently holds a Momentum Style Score of A, indicating strong potential for momentum investing [3] - NHI has a Zacks Rank of 2 (Buy), suggesting it is positioned for outperformance in the market [4] Group 2: Price Performance - Over the past week, NHI shares increased by 5.84%, outperforming the Zacks REIT and Equity Trust - Other industry, which rose by 3.92% [6] - In a longer timeframe, NHI shares have risen by 24.15% over the past quarter and 57.29% over the last year, significantly outperforming the S&P 500's gains of 8.19% and 26.56%, respectively [7] Group 3: Trading Volume - NHI's average 20-day trading volume is 259,269 shares, which serves as a bullish indicator when combined with rising stock prices [8] Group 4: Earnings Outlook - In the past two months, two earnings estimates for NHI have been revised upwards, increasing the consensus estimate from $4.40 to $4.52 [10] - For the next fiscal year, two estimates have also moved upwards, with no downward revisions, indicating positive earnings momentum [10]

National Health Investors (NHI) came out with quarterly funds from operations (FFO) of $1.18 per share, beating the Zacks Consensus Estimate of $1.10 per share. This compares to FFO of $1.06 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an FFO surprise of 7.27%. A quarter ago, it was expected that this health care real estate investment trust would post FFO of $1.05 per share when it actually produced FFO of $1.10, delivering a surprise of 4.76%. ...

On our last update on National Health Investors, Inc. (NYSE:NHI) we saw some green shoots that were working well for the REIT. We even preferred NHI over some other REITs in the sector. NHI has navigated the COVID-19 problems quite well. If you look at total FFO lost from pre-COVID-19 levels, you can see that NHI lost about 20% of its pre-COVID-19 FFO. Ventas (VTR) by comparison has lost about 24%. Sabra Health Care (SBRA) has lost closer to 30%. What's most impressive though for NHI is that its debt to EBI ...

While many investors like to look for momentum in stocks, this can be very tough to define. There is a lot of debate surrounding which metrics are the best to focus on and which are poor quality indicators of future performance. The Zacks Momentum Style Score, part of the Zacks Style Scores, helps address this issue for us. You can see the current list of Zacks #1 Rank Stocks here >>> Looking at a stock's short-term price activity is a great way to gauge if it has momentum, since this can reflect both the c ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades. Below, we take a look at National Health In ...

Monty Rakusen Dear readers/followers, I invest in and cover a lot of different REITs and real estate companies. One of the companies I have covered and have a small position in since earlier is the REIT National Health Investors (NYSE:NHI). Unfortunately for me, this is not a very large position - simply because I believe that there are better alternatives for conservative investment out there. That is not to say that this company is in any way a "bad" investment or potential option - but there are chal ...

For the quarter ended March 2024, National Health Investors (NHI) reported revenue of $81.51 million, down 1.1% over the same period last year. EPS came in at $1.10, compared to $0.79 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $79.36 million, representing a surprise of +2.71%. The company delivered an EPS surprise of +4.76%, with the consensus EPS estimate being $1.05.While investors closely watch year-over-year changes in headline numbers -- revenue and earning ...

• Net income attributable to common stockholders per diluted common share for the three months ended March 31, 2024 was $0.71 compared to $0.79 during the same period in the prior year. • National Association of Real Estate Investment Trusts ("NAREIT") FFO per diluted common share for the three months ended March 31, 2024 was $1.10 compared to $1.16 during the same period in the prior year. • Normalized FFO per diluted common share for the three months ended March 31, 2024 was $1.12 compared to $1.11 during ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) Commission File Number 001-10822 National Health Investors, Inc. (Exact name of registrant as specified in its charter) Maryland 62-1470956 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 222 Robert Rose Drive Murfreesboro Tennessee 37129 (Address of principal executive offices) (Zip Code) (615) 890-9100 (Registrant's telephone number, including area code) Securiti ...

• Rental income recognized from the Company's tenants, including the effects of straight-line lease revenue and property taxes and insurance on leased properties, increased $7.0 million primarily from an increase in pandemic-related rent repayments of approximately $2.6 million and new investments funded since December 2022. The amortization of lease incentives increased by $2.2 million primarily related to a $10.0 million lease incentive paid in February 2023; • Net income attributable to common stockholde ...